Last reviewed: June 20, 2026
Last updated: June 20, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic (semaglutide) was originally approved by the FDA for type 2 diabetes, but the GLP-1 receptor agonist has gained attention for weight management in people with obesity. Understanding the medical requirements for semaglutide treatment helps you determine if this therapy aligns with your health goals and clinical profile.
Body Mass Index and Weight Loss Eligibility Thresholds
Medical eligibility for semaglutide weight loss typically begins at a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or cardiovascular disease. BMI serves as an initial screening tool, though it does not measure body composition or metabolic function directly. A healthcare provider evaluates your individual circumstances, weight history, and metabolic markers to confirm candidacy. PlexusDx providers assess these criteria during your consultation to determine if compounded semaglutide injection or oral semaglutide matches your clinical profile.
Some patients with a BMI between 27 and 30 may qualify if they have documented obesity-related conditions, including sleep apnea, non-alcoholic fatty liver disease, or prediabetes. Age, sex, and medication interactions also influence individual eligibility. PlexusDx compounded semaglutide delivers the active GLP-1 compound at doses tailored to your metabolic response, and pricing remains flat at $149/month regardless of dose adjustments—your dose may need to go up, your price won't.
Cardiovascular Health and Medical History Requirements
A thorough cardiovascular assessment is essential before starting semaglutide, as GLP-1 receptor agonists affect appetite regulation and metabolic pathways that influence heart rate and blood pressure. Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 are contraindicated from semaglutide use due to animal study findings. Providers also review kidney function, liver function, and gastrointestinal motility to identify any conditions that might require dose adjustment or alternative therapies.
Pancreatitis history, gallbladder disease, and severe gastroparesis warrant careful provider review before treatment initiation. PlexusDx requires a consultation with its licensed providers to evaluate your complete medical history, current medications, and past adverse reactions. This personalized assessment ensures semaglutide therapy is safe and appropriate for your unique health status.
Metabolic Testing and Lab Requirements Before Starting Treatment
Before initiating semaglutide, baseline laboratory work typically includes fasting glucose, hemoglobin A1C, lipid panel, liver function tests, kidney function tests, and thyroid-stimulating hormone (TSH). These measurements establish your metabolic baseline and identify underlying conditions that might influence treatment response or safety. Fasting glucose and A1C levels help providers understand your insulin sensitivity and risk for diabetes progression, while TSH screening rules out thyroid dysfunction that could complicate GLP-1 therapy.
PlexusDx providers order these standard labs as part of the initial medical consultation. After your first month of treatment, you may qualify for PlexusDx's Precision Peptide Genetic Test ($99 add-on), which identifies genetic variations in the GLP1R, GIPR, FTO, and MC4R pathways—14 total peptide pathways across 49 peptides. This genetic insight reveals your inherited predisposition to GLP-1 response and metabolic trait expression, enabling truly personalized dose optimization and compound selection between semaglutide and tirzepatide.
Insurance, Documentation, and Access Through PlexusDx
PlexusDx compounded semaglutide injection and oral formulations require no insurance, no membership fee, and no prior authorization. The service is available across all 50 states and accepts HSA and FSA funds, making treatment accessible to patients seeking affordable alternatives to brand-name Ozempic. Compounded medications from PlexusDx come from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and sterility.
Your eligibility for PlexusDx semaglutide treatment depends on completing a medical history form, telehealth consultation with a licensed provider, and baseline lab review. Once approved, you receive your compounded semaglutide injection starting at $149/month (flat pricing across commitment tiers), or switch to oral semaglutide at $249/month if injections are not preferred. PlexusDx also offers dual-compound GLP-Squared formulations (semaglutide + tirzepatide) and the Microdose GLP-1 Protocol at $129/month for patients exploring lower-dose initiation with extended titration schedules.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the minimum BMI required to qualify for Ozempic or semaglutide weight loss?
Standard eligibility begins at BMI 30 or higher, or BMI 27+ with obesity-related comorbidities such as hypertension, type 2 diabetes, or sleep apnea. PlexusDx providers evaluate your complete health profile during consultation to confirm candidacy, as individual circumstances vary.
Do I need lab work before starting semaglutide for weight loss?
Yes, baseline fasting glucose, A1C, lipid panel, liver and kidney function, and TSH are standard screening tests. These labs establish your metabolic baseline and identify any contraindications before PlexusDx providers approve your treatment plan.
Can I use HSA or FSA funds to pay for PlexusDx semaglutide?
Yes, PlexusDx compounded semaglutide injection ($149/month) and oral semaglutide ($249/month) are both HSA and FSA eligible. No insurance is required, and PlexusDx serves all 50 states with no membership fee.
Are there any medical conditions that disqualify me from semaglutide therapy?
Personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia type 2 are contraindications. Pancreatitis history, severe gastroparesis, and active gallbladder disease may require careful provider review. PlexusDx providers assess these conditions during consultation.
How does PlexusDx Precision Peptide Genetic Testing help optimize my semaglutide dosing?
The Precision Peptide Genetic Test ($99 add-on after month one) identifies genetic variants in GLP1R, GIPR, FTO, and MC4R pathways, revealing your inherited predisposition to GLP-1 response across 14 peptide pathways and 150+ genetic insights. This data guides dose titration and compound selection between semaglutide and tirzepatide for maximum efficacy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic and Weight Loss: Is It Healthy for Your Journey?
Does Zepbound Affect Your Heart? Exploring the Impact of Weight Loss Medications on Cardiovascular Health